Facial psoriasis: can you do filler or botulinum toxin?

When a patient has psoriasis on the face, the first reaction is fear of being turned away. The second is worry that the procedure will make the disease worse. Both fears are well founded, but neither automatically leads to a "no". What changes is the timing: with the skin in an active phase, you postpone; with the disease controlled and the skin intact in the area, the case can be discussed.

This page organizes the assessment and the conversation. It does not replace the opinion of the physician who follows the psoriasis, who should be consulted whenever there is doubt. Approach and indication are up to the licensed professional, according to the rules of their professional council (in Brazil).

What matters about psoriasis for the injector

Psoriasis is a chronic inflammatory skin disease, with flare and remission phases. On the face, it shows up as red, scaly plaques, most common at the hairline, on the eyebrows, in the folds of the nose and behind the ears. What matters to you:

• Active lesion in the area: plaques, scaling, fissures or redness where the needle would go.
• Koebner phenomenon: in some patients, skin trauma can trigger a new lesion at the site.
• Medications in use: treatments that act on immunity can increase the risk of infection.
• Phase of the disease: recent flare or stable.

Why does Koebner deserve attention?

The Koebner phenomenon is the appearance of a psoriatic lesion at a site of trauma, such as a scratch, burn or bite. Not every patient with psoriasis has it, but anyone who has had it on cuts or tattoos is on alert. In a cosmetic procedure, the small trauma of the needle can, in theory, trigger a lesion at the entry points. That is not a reason to deny the procedure to everyone, but it is a reason to ask and to document.

Immunosuppressants and biologics

Many patients with psoriasis take medications that lower immune system activity. These treatments can increase the chance of local infection and change healing. That does not mean an automatic refusal, but it calls for a conversation with the prescribing physician, especially if multiple procedures are planned. In each case, the decision and the precautions (strict asepsis, observation, early follow-up) are up to the professional. For a related topic, see corticosteroids and cosmetic procedures.

Toxin and filler: does it make a difference?

Botulinum toxin uses a fine needle and few points; filler with hyaluronic acid can involve more points or a cannula, and more manipulation. In both, the skin must be intact at the site. There is no absolute contraindication described for psoriasis itself, but caution is greater when the disease is active or unstable. When there are signs of a reaction after the procedure, the topic overlaps with itching after filler and seborrheic dermatitis and procedures.

Step-by-step assessment

How to talk to the patient

Take the weight off the "can or can't". Explain that the disease has phases and that the right time is when the skin is calm. Patients with psoriasis often have their self-esteem shaken by visible lesions, and a curt refusal can hurt. Show that postponing is care, not rejection.

After the procedure

At follow-up, look for lesions at the injection points, increased redness or scaling. Tell the patient to let you know early. Skin with psoriasis tends to be more sensitive, and irritating products should be avoided. The daily care routine should be the one the dermatologist recommended.

What Harmy does, and what it does not do

Harmy simulates the result of volume procedures from a frontal photo, but it does not assess the skin or the disease. It can help you discuss the plan once the skin is ready, making clear that the simulation is illustrative, not a promise of results. The decision to inject never depends on the image, only on the clinical assessment.

In short: facial psoriasis is not an automatic "no", but a "when and how". Intact skin, a stable disease and agreement with the treating physician are the way forward.